dm+d
13568411000001103
Articles
Understanding direct oral anticoagulant (DOAC) interactions
5 January 2024
Using intramuscular injections in people on oral anticoagulants
20 September 2023
Accessing resources for patients on high risk medicines
19 December 2022A number of resources are available to support the safe use of high-risk medicines. Healthcare professionals should ensure they are available for their patients
Using oral anticoagulants during breastfeeding
2 November 2021Thromboembolic disease management whilst breastfeeding is challenging. Warfarin is the preferred choice. Guidance on using DOACs is also provided.
Medicine Compliance Aid Stability
PradaxaBoehringer Ingelheim
Boehringer Ingelheim
Pradaxa
Capsules 75mg, 110mg, 150mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Very sensitive to moisture so should be left in individual foil wrapping.
7 November 2022
Lactation Safety Information
Warfarin, Rivaroxaban
Direct thrombin inhibitor
Very limited published evidence of safety indicates negligible levels in milk
Minimal absorption from the infant’s GI tract expected due to low oral bioavailability
Monitor infant for bleeding and bruising
1 November 2021